Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain and Morphine Consumption on Patients After Robotic Assisted Laparoscopic Radical Prostatectomy

This study is currently recruiting participants.

Verified by Benaroya Research Institute, March 2009

First Received: March 17, 2009 No Changes Posted

Sponsors and Collaborators:	Benaroya Research Institute Virginia Mason Medical Center, Departments of Urology and Anesthesiology
Information provided by:	Benaroya Research Institute
ClinicalTrials.gov Identifier:	NCT00863928

Purpose

This study is evaluating the effect of a Belladonna and Opium suppository administered intraoperatively on post operative pain after laparoscopic radical prostatectomy for prostate cancer. This is a blinded randomized study.

50% of patients will receive the suppository, 50% of patients will not. Neither you or your surgeon will know which group you are in.

Condition	Intervention
Pain Management	Drug: Belladonna and Opium Suppositories

Study Type:	Interventional
Study Design:	Treatment, Single Group Assignment
Official Title:	Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain and Morphine Consumption on Patients After Robotic Assisted Laparoscopic Radical Prostatectomy

Resource links provided by NLM:

Drug Information available for: Papaveretum Belladonna Opium

U.S. FDA Resources

Further study details as provided by Benaroya Research Institute:

Intervention Details:

Effects of Perioperative Belladonna and Opium Suppositories on Postoperative Pain

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Patients scheduled for laparoscopic radical prostatectomy at Virginia Mason, who do not have chronic pain or allergies to opioid analgesics are eligible for this study.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00863928

Contacts

Contact: Erin Odom

1-800-354-9527 Ext.10369

Erin.Odom@vmmc.org

Locations

United States, Washington
Virginia Mason Medical Center	Recruiting
Seattle, Washington, United States, 98101

Sponsors and Collaborators

Benaroya Research Institute

Virginia Mason Medical Center, Departments of Urology and Anesthesiology

More Information

No publications provided

Responsible Party:	Virginia Mason Medical Center ( John Corman )
Study ID Numbers:	IRB08100, 370
Study First Received:	March 17, 2009
Last Updated:	March 17, 2009
ClinicalTrials.gov Identifier:	NCT00863928 History of Changes
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Morphine
Central Nervous System Depressants
Pain
Loperamide
Narcotics
Antidiarrheals
Naphazoline
Signs and Symptoms
Belladonna

Postoperative Complications
Guaifenesin
Opium
Peripheral Nervous System Agents
Analgesics
Phenylpropanolamine
Analgesics, Opioid
Pain, Postoperative

Additional relevant MeSH terms:

Respiratory System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Central Nervous System Depressants
Narcotics
Pain
Pharmacologic Actions
Antidiarrheals
Signs and Symptoms
Pathologic Processes

Postoperative Complications
Sensory System Agents
Therapeutic Uses
Opium
Peripheral Nervous System Agents
Analgesics
Antitussive Agents
Central Nervous System Agents
Analgesics, Opioid
Pain, Postoperative

ClinicalTrials.gov processed this record on September 11, 2009